Chapter 28: The Central Nervous System: Pathology and Disease

The Central Nervous System: Pathology and Disease exploration of clinical neuropathology details the complex physiological and structural responses of the brain and spinal cord to injury, disease, and developmental anomalies. The study begins with the cellular foundations of the central nervous system, examining how neurons, astrocytes, and microglia undergo morphologic transformations like gliosis and neuronophagia in response to metabolic or physical stress. It provides a critical analysis of intracranial pressure dynamics, defining the pathophysiology of vasogenic and cytotoxic edema, the various forms of hydrocephalus, and the life-threatening mechanics of brain herniation. The text systematically categorizes developmental disorders, from common neural tube defects and forebrain malformations to complex posterior fossa anomalies. A significant portion of the material is dedicated to cerebrovascular health, distinguishing the mechanisms of global hypoxia from focal ischemia while detailing the progression of nonhemorrhagic and hemorrhagic infarcts, the rupture of saccular aneurysms, and the causes of vascular dementia. Traumatic injuries are analyzed through the lens of concussions, parenchymal contusions, and the clinical emergency of epidural and subdural hematomas. The infection section covers the spectrum of bacterial meningitis, fungal invasions, and viral encephalitis, including the unique neurological impacts of HIV and the JC polyomavirus. Extensive detail is provided on the molecular basis of neurodegeneration, focusing on the protein misfolding and aggregation seen in Alzheimer’s disease, Parkinson’s disease, Huntington’s chorea, and motor neuron diseases like ALS. Furthermore, the chapter addresses demyelinating conditions such as multiple sclerosis and examines the genetic and metabolic underpinnings of leukodystrophies. Finally, the discussion of neuro-oncology classifies primary intraparenchymal tumors like gliomas and medulloblastomas, alongside dura-based meningiomas and the widespread impact of metastatic carcinomas and paraneoplastic syndromes.